These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 2925799

  • 1. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells.
    Eisman JA, Sutherland RL, McMenemy ML, Fragonas JC, Musgrove EA, Pang GY.
    J Cell Physiol; 1989 Mar; 138(3):611-6. PubMed ID: 2925799
    [Abstract] [Full Text] [Related]

  • 2. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells.
    Sutherland RL, Hall RE, Taylor IW.
    Cancer Res; 1983 Sep; 43(9):3998-4006. PubMed ID: 6871841
    [Abstract] [Full Text] [Related]

  • 3. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
    Koga M, Eisman JA, Sutherland RL.
    Cancer Res; 1988 May 15; 48(10):2734-9. PubMed ID: 2834048
    [Abstract] [Full Text] [Related]

  • 4. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 5. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
    Sutherland RL, Hall RE, Pang GY, Musgrove EA, Clarke CL.
    Cancer Res; 1988 Sep 15; 48(18):5084-91. PubMed ID: 2970295
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen.
    Reddel RR, Murphy LC, Sutherland RL.
    Cancer Res; 1984 Jun 15; 44(6):2398-405. PubMed ID: 6722780
    [Abstract] [Full Text] [Related]

  • 8. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR, Sutherland RL.
    Cancer Res; 1987 Oct 15; 47(20):5323-9. PubMed ID: 3652038
    [Abstract] [Full Text] [Related]

  • 9. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Oct 15; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 10. Cell cycle sensitivity of HL-60 cells to the differentiation-inducing effects of 1-alpha,25-dihydroxyvitamin D3.
    Studzinski GP, Bhandal AK, Brelvi ZS.
    Cancer Res; 1985 Aug 15; 45(8):3898-905. PubMed ID: 3860289
    [Abstract] [Full Text] [Related]

  • 11. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 15; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
    Campbell MJ, Reddy GS, Koeffler HP.
    J Cell Biochem; 1997 Sep 01; 66(3):413-25. PubMed ID: 9257197
    [Abstract] [Full Text] [Related]

  • 13. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y, Knutson JC, Bishop C, Shany S.
    Anticancer Res; 1998 Sep 01; 18(3A):1769-75. PubMed ID: 9673403
    [Abstract] [Full Text] [Related]

  • 14. 1,25-Dihydroxyvitamin D3 and the regulation of human cancer cell replication.
    Eisman JA, Koga M, Sutherland RL, Barkla DH, Tutton PJ.
    Proc Soc Exp Biol Med; 1989 Jul 01; 191(3):221-6. PubMed ID: 2740355
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK, Boldt DH, Estrada P.
    Cancer Res; 1984 Apr 01; 44(4):1433-9. PubMed ID: 6704960
    [Abstract] [Full Text] [Related]

  • 17. Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase.
    Osborne CK, Boldt DH, Clark GM, Trent JM.
    Cancer Res; 1983 Aug 01; 43(8):3583-5. PubMed ID: 6861130
    [Abstract] [Full Text] [Related]

  • 18. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J, Kubota T, Hisatake Y, Uskokovic M, Tomoyasu S, Koeffler HP.
    Cancer Res; 1999 Aug 15; 59(16):4023-9. PubMed ID: 10463602
    [Abstract] [Full Text] [Related]

  • 19. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 15; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 20. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR, Murphy LC, Hall RE, Sutherland RL.
    Cancer Res; 1985 Apr 15; 45(4):1525-31. PubMed ID: 3978620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.